Detalles de la búsqueda
1.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764356
2.
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.
Clin Exp Hypertens
; 41(7): 637-644, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373408
3.
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Hypertens Res
; 47(3): 628-638, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848562
4.
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Front Pharmacol
; 15: 1358573, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601470
5.
Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes.
Clin Exp Nephrol
; 17(6): 866-71, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23543049
6.
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.
PLoS Genet
; 6(2): e1000842, 2010 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20168990
7.
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Diab Vasc Dis Res
; 20(6): 14791641231222837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096503
8.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Cardiovasc Endocrinol Metab
; 12(4): e0292, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779602
9.
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Diabetes Res Clin Pract
; 185: 109231, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131376
10.
Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes.
Clin Exp Nephrol
; 15(3): 381-390, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21331741
11.
Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Clin Exp Hypertens
; 33(4): 255-63, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21699452
12.
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models.
J Diabetes Investig
; 12(1): 74-81, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32506833
13.
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Diabetes Technol Ther
; 23(2): 110-119, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721227
14.
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
J Diabetes Res
; 2019: 9415313, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31781668
15.
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
Diab Vasc Dis Res
; 16(1): 103-107, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30284913
16.
Detection of Autonomic Nervous System Abnormalities in Diabetic Patients by 24-hour Ambulatory Blood Pressure Monitoring.
Tokai J Exp Clin Med
; 43(3): 97-102, 2018 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30191543
17.
A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.
PLoS One
; 13(12): e0208654, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30566433
18.
Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
J Nephrol
; 19(6): 751-7, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17173248
19.
[Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
Nihon Jinzo Gakkai Shi
; 48(1): 14-21, 2006.
Artículo
en Japonés
| MEDLINE | ID: mdl-16480062
20.
Exercise Therapy for Management of Type 2 Diabetes Mellitus: Superior Efficacy of Activity Monitors over Pedometers.
J Diabetes Res
; 2016: 5043964, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27761471